-+ 0.00%
-+ 0.00%
-+ 0.00%

cbdMD backs bipartisan bill to avert December ban on hemp-derived products

PUBT·11/18/2026 13:10:32
Listen to the news
cbdMD backs bipartisan bill to avert December ban on hemp-derived products
  • cbdMD backed bipartisan legislation introduced November 17 to avert a December 11, 2026, hemp redefinition that would effectively ban many lawful products.
  • The Hemp Guardrails Act would establish federal oversight of hemp-derived products, restricting sales to adults 21 and older while imposing safety standards.
  • The bill would require US cultivation, processing and packaging, while directing FDA to establish manufacturing, testing and recall standards.
  • Passage would open a federal pathway for hemp-derived dietary supplements; the company urged inclusion in the year-end funding package before December 11.
  • Recent acquisitions of Twinlab, Metabolife and Reserveage diversify the business beyond hemp-derived cannabinoids, reducing exposure to regulatory changes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. cbdMD Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202611180810ACCESSWRNAPR_____1253291) on November 18, 2026, and is solely responsible for the information contained therein.